A Phase II/III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Determine the Efficacy and Safety of ABC008 in the Treatment of Subjects with Inclusion Body Myositis
Details
Age
Adult
Locations
Outpatient CTRC
Principal Investigator
Stacy Dixon
Study ID
Protocol Number: 23-0008
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers